Baidu
map

J Sleep Res:研究发现失眠治疗并未有益于预防或治疗心血管疾病

2021-04-12 MedSci原创 MedSci原创

根据世界卫生组织的数据,心血管疾病是世界上的主要死亡原因。因此,及早预防这些疾病是公共卫生的优先事项。流行病学数据表明,失眠可能是心血管疾病的一个可改变的危险因素。为了评估失眠治疗对心血管疾病早期标志

根据世界卫生组织的数据,血管疾病是世界上的主要死亡原因。因此,及早预防这些疾病是公共卫生的优先事项。流行病学数据表明,失眠可能是心血管疾病的一个可改变的危险因素。为了评估失眠治疗对心血管疾病早期标志物的影响,研究人员进行了一项随机对照试验,结果已发表于J Sleep Res。

研究纳入了46名没有心血管疾病的失眠患者,调查失眠治疗对患者24小时动态血压、心率和心率变异性监测以及早晨空腹血样评估的心血管疾病早期标志物的影响。

 

患者随机接受失眠症认知行为治疗(CBT-I;n = 23)和对照治疗(n = 23)。结果显示,尽管失眠治疗成功(d = 1.3),但是意向治疗分析并未显示出对心血管疾病早期标志物有任何显著影响(d = 0.0-0.6)。

综上所述,该研究并未发现失眠治疗对心血管疾病有预防或治疗作用。未来需要更大样本来那个的研究行进一步的探究。

 

原始出处:

 

Anna Friederike Johann, et al., Cognitive behavioural therapy for insomnia does not appear to have a substantial impact on early markers of cardiovascular disease: A preliminary randomized controlled trial. J Sleep Res. 2020 Oct;29(5):e13102. doi: 10.1111/jsr.13102.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1753584, encodeId=8f7c1e5358439, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Nov 25 21:10:04 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345041, encodeId=8b5213450413b, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Apr 13 12:10:04 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498861, encodeId=a3921498861d7, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Apr 13 12:10:04 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956248, encodeId=c4ef9562482e, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 12 18:10:56 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1753584, encodeId=8f7c1e5358439, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Nov 25 21:10:04 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345041, encodeId=8b5213450413b, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Apr 13 12:10:04 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498861, encodeId=a3921498861d7, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Apr 13 12:10:04 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956248, encodeId=c4ef9562482e, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 12 18:10:56 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
    2021-04-13 heli0118
  3. [GetPortalCommentsPageByObjectIdResponse(id=1753584, encodeId=8f7c1e5358439, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Nov 25 21:10:04 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345041, encodeId=8b5213450413b, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Apr 13 12:10:04 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498861, encodeId=a3921498861d7, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Apr 13 12:10:04 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956248, encodeId=c4ef9562482e, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 12 18:10:56 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1753584, encodeId=8f7c1e5358439, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Nov 25 21:10:04 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345041, encodeId=8b5213450413b, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16404, encryptionId=cf721640495, topicName=SLE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Tue Apr 13 12:10:04 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498861, encodeId=a3921498861d7, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Apr 13 12:10:04 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956248, encodeId=c4ef9562482e, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 12 18:10:56 CST 2021, time=2021-04-12, status=1, ipAttribution=)]
    2021-04-12 jyzxjiangqin

    好文章!

    0

相关资讯

失眠严重程度指数量表(ISI)

失眠严重程度指数量表(ISI)

JAMA Network Open:13.9%的基线健康人群5年内会出现失眠综合症

失眠是一个严重的公共健康问题,虽然失眠症的病理生理特征在很大程度上仍不为人所知,但越来越多的证据表明持续性失眠症与长期不良后果有关,如心理风险(如抑郁)、职业风险(旷工)和医学发病率(如高血压)的增加

J Ethnopharmacol:Ashwagandha根提取物可以提高睡眠质量,有助于管理失眠

睡眠是人类健康中最重要的生理方面之一,有助于能量的循环、活力和恢复活力。失眠已成为最常见的睡眠障碍,发病率很高,严重影响患者的生活质量和认知功能。长期以来,Ashwagandha因其诱导睡眠的作用而闻

Alzheimers Dement:Suvorexant可改善疑似AD痴呆和失眠患者的睡眠情况

一项随机、双盲临床试验评估了orexin受体拮抗剂suvorexant治疗轻中度疑似阿尔茨海默病(AD)痴呆患者失眠的临床情况,研究结果已在线发表于Alzheimers Dement。

JAMA Netw Open:失眠吗?那就打打太极拳

据数据显示,全球超过50%的老年人有睡眠障碍,其中失眠率高达20%至40%。失眠和持续的睡眠障碍会影响生活质量,并有可能增加死亡率和发病率。

焦虑 抑郁 失眠……美国加州近半ICU医护人员面临心理问题

据美国哥伦比亚广播公司27日报道,在新冠肺炎疫情严重的加利福尼亚州,当地累计死亡病例已经达到近52000例。虽然近期加州的住院病例和感染人数有所下降,但当地医疗系统持续承受巨大压力,一线重症监护室医护

Baidu
map
Baidu
map
Baidu
map